ng-nitroarginine methyl ester has been researched along with Cochlear Hearing Loss in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anniko, M; Maeta, M | 1 |
| Anniko, M; Nordang, L | 1 |
| Anniko, M; Popa, R; Takumida, M | 1 |
3 other study(ies) available for ng-nitroarginine methyl ester and Cochlear Hearing Loss
| Article | Year |
|---|---|
Protective effect of brain-derived neurotrophic factor against the ototoxicity of Pseudomonas aeruginosa exotoxin A.
Topics: ADP Ribose Transferases; Animals; Audiometry, Pure-Tone; Auditory Fatigue; Auditory Threshold; Bacterial Toxins; Brain-Derived Neurotrophic Factor; Cochlear Nerve; Ear, Middle; Evoked Potentials, Auditory, Brain Stem; Exotoxins; Hearing Loss, Sensorineural; Male; Neuroprotective Agents; NG-Nitroarginine Methyl Ester; Pitch Perception; Pseudomonas aeruginosa Exotoxin A; Round Window, Ear; Virulence Factors | 2003 |
Nitro-L-arginine methyl ester: a potential protector against gentamicin ototoxicity.
Topics: Animals; Anti-Bacterial Agents; Enzyme Inhibitors; Evoked Potentials, Auditory, Brain Stem; Gentamicins; Hearing Loss, Sensorineural; Male; NG-Nitroarginine Methyl Ester; Rats; Rats, Sprague-Dawley; Reaction Time | 2005 |
Otoprotectant minimizes hearing defects caused by Pseudomonas aeruginosa exotoxin A.
Topics: Animals; Auditory Threshold; Cochlea; Dizocilpine Maleate; Enzyme Inhibitors; Evoked Potentials, Auditory, Brain Stem; Exotoxins; Hearing Loss, Conductive; Hearing Loss, High-Frequency; Hearing Loss, Sensorineural; NG-Nitroarginine Methyl Ester; Nitric Oxide; Pseudomonas aeruginosa; Pseudomonas Infections; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Severity of Illness Index | 2000 |